Review Article
Systemic Lupus Erythematosus: Recent Concepts in Genomics, Pathogenetic Mechanisms, and Therapies
Table 4
Summary of newer therapies for SLE.
| Biological agents | Rituximab | Ocrelizumab | Belimumab | Epratuzumab | Atacicept | Tocilizumab | Infliximab | Abatacept |
| Anticytokine therapies | Anti-TNFα | Anti-IFNy | Anti-interleukin 10 | Anti-interleukin 6 receptor | Anti-interleukin 1 receptor | Anti- IFNα |
| Other techniques | Immunoadsorption | Anti-C5a | Peptide therapies | T cell vaccination | Costimulation inhibition with anti-CD154 | B cell anergy with abetimus |
|
|